Development and Validation of Stability-indicating assay UHPLC Method for Simultaneous analysis of Dolutegravir, Lamivudine and Tenofovir disoproxil fumarate in Bulk and Pharmaceutical Formulation

Balaji Thakare; Abhilasha Mittal; Manoj Charde; Rahul Umbarkar; Nitin Kohle; Piyush Chandra; Manoj Kadam

doi:10.52711/0974-360X.2022.00681

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Development and Validation of Stability-indicating assay UHPLC Method for Simultaneous analysis of Dolutegravir, Lamivudine and Tenofovir disoproxil fumarate in Bulk and Pharmaceutical Formulation

Author(s): Balaji Thakare, Abhilasha Mittal, Manoj Charde, Rahul Umbarkar, Nitin Kohle, Piyush Chandra, Manoj Kadam

Email(s): balaji.thakare2@gmail.com

DOI: 10.52711/0974-360X.2022.00681

Address: Balaji Thakare1*, Abhilasha Mittal1, Manoj Charde2, Rahul Umbarkar2, Nitin Kohle1, Piyush Chandra1, Manoj Kadam1
1Department of Pharmaceutical Chemistry, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan 303121.
2Government College of Pharmacy, Vidhya Nagar, Karad, Dist. Satara, Karad 415603 M.S.
*Corresponding Author

Published In: Volume - 15, Issue - 9, Year - 2022

Keywords:

Cite this article:
Balaji Thakare, Abhilasha Mittal, Manoj Charde, Rahul Umbarkar, Nitin Kohle, Piyush Chandra, Manoj Kadam. Development and Validation of Stability-indicating assay UHPLC Method for Simultaneous analysis of Dolutegravir, Lamivudine and Tenofovir disoproxil fumarate in Bulk and Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2022; 15(9):4061-6. doi: 10.52711/0974-360X.2022.00681

View PDF